Canopy Growth Q2 FY27 net loss widens to CAD 40.69 million

By Public Technologies
  • Canopy Growth's Q2 FY27 net loss widened year-over-year to CAD 40.69 million, primarily due to fair-value charges on Canopy USA-related assets.
  • Net revenue rose 22% year-over-year to CAD 81.37 million, while the Cannabis segment posted 30% growth to CAD 66.24 million.
  • International markets cannabis net revenue more than doubled to CAD 12.27 million, primarily driven by strong sales in Germany and Poland.
  • The Smiths Falls facility received EU GMP certification, expanding the international supply chain, while medical cannabis distribution expanded into the U.K.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canopy Growth Corp. published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.